Ledger.Open graph →

SEC Form D · filed August 14, 2020

Dyne Therapeutics, Inc

Offering

$115.7M

Sold

$115.7M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WALTHAM, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Richard Scalzo · Brevard, NCExec Joshua Brumm · Waltham, MAExec · Director David Lubner · Waltham, MADirector Lawrence Klein, Ph.D · Waltham, MADirector Edward Hurwitz · Waltham, MADirector Dirk Kersten · Waltham, MADirector Jonathan Mcneill, M.D · Waltham, MAExec Catherine Stehman-Breen, M.D · Waltham, MADirector Jason Rhodes · Cambridge, MADirector Oxana Beskrovnaya, Ph.D · Waltham, MAExec Romesh Subramanian, Ph.D · Waltham, MAExec Lawrence Klein, Ph.D · Waltham, MADirector Richard Scalzo · Waltham, MAExec Joshua Brumm · Waltham, MAExec · Director David Lubner · Waltham, MADirector Edward Hurwitz · Waltham, MADirector Dirk Kersten · Waltham, MADirector Jonathan Mcneill, M.D · Waltham, MAExec Catherine Stehman-Breen, M.D · Waltham, MADirector Jason Rhodes · Cambridge, MADirector Oxana Beskrovnaya, Ph.D · Waltham, MAExec Romesh Subramanian, Ph.D · Waltham, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗